# Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users

> **NCT07092709** · PHASE3 · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 912 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07092709
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-14
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 912 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07092709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07092709, "Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07092709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*